Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›Towards a Better Understanding of the Neurological Effects…

U.S. National Institutes of Health·United States of America

Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R01 - Clinical Trial Optional)

Closes 11/5/2025$200k – $500kGrants Notice
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The National Institutes of Health (NIH) is soliciting applications for a research grant focused on the neurological and mental health-related manifestations of infection-associated chronic illnesses, including the post-acute sequelae of COVID-19 (Neuro-PASC) and other chronic illnesses with a potential infectious trigger. The grant aims to support projects that investigate common neurological and mental health-related mechanisms across multiple infection-associated chronic illnesses. The research should be focused on the development of effective treatments for these conditions. • The grant will utilize the R01 activity code. • The application due date is November 5, 2025. • The award is expected to be made on December 1, 2025. • The project start date is expected to be December 1, 2025. • The grant is open to various types of organizations, including public and private institutions of higher education, non-profits, and small businesses.

Attached files

The solicitation documents live at the source — open the bid source above to download them.

Contact

[email protected]

(301) 402-2541

Key dates

Opened
10/17/2024
Closes
11/5/2025
Projected award
12/1/2025

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541712
Solicitation №
PAR-25-116

Budget estimate

$200,000 – $500,000

The budget for this grant is estimated to be around $500,000, as specified in the award ceiling. However, the actual budget may vary depending on the specific project and the NIH's budget. The budget is likely to be a one-time payment, but it may be disbursed over several years, depending on the project's timeline and milestones. The factors that may influence the likely payment range include the complexity of the research project, the number of personnel involved, the duration of the project, and the availability of funds.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 71%

BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)

Closes 11/8/2027Opened 5/22/2025

U.S. National Institutes of Health·United States of America

70% match

BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed)

Closes 2/8/2029Opened 8/28/2025

U.S. National Institutes of Health·United States of America

70% match

BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed)

Closes 2/11/2027Opened 6/9/2025

U.S. National Institutes of Health·United States of America

70% match

New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)

Closes 5/7/2027Opened 3/19/2024

U.S. National Institutes of Health·United States of America

70% match

Causal Hypotheses on the Oral-Systemic Health Impacts of Human Behaviors among People with Chronic Conditions (U01 Clinical Trial Not Allowed)

Closes 7/5/2029Opened 7/29/2025

U.S. National Institutes of Health·United States of America

69% match

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)

Closes 1/7/2028Opened 3/25/2021

U.S. National Institutes of Health·United States of America

69% match

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. National Institutes of Health·United States of America

69% match

Development of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)

Closes 1/7/2028Opened 10/28/2024

U.S. National Institutes of Health·United States of America

68% match

Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. National Institutes of Health·United States of America

68% match

BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)

Closes 1/28/2027Opened 3/19/2024

U.S. National Institutes of Health·United States of America

68% match

BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)

Closes 2/8/2027Opened 6/16/2023

U.S. National Institutes of Health·United States of America

68% match

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Closes 5/24/2027Opened 9/23/2026

U.S. National Institutes of Health·United States of America

68% match

Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)

Closes 6/17/2027Opened 6/6/2025

U.S. National Institutes of Health·United States of America

68% match

Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)

Closes 11/18/2026Opened 10/30/2023

U.S. National Institutes of Health·United States of America

68% match

Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)

Closes 1/7/2028Opened 10/31/2024

U.S. National Institutes of Health·United States of America

68% match

Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) Infrastructure ? Clinical Research Sites (U24 Clinical Trial Not Allowed)

Closes 10/31/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

68% match

NIDCD Cooperative Agreement for Clinical Trials in Communication Disorders (U01 - Clinical Trial Required)

Closes 10/18/2027Opened 10/20/2023

U.S. National Institutes of Health·United States of America

68% match

BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System

Closes 1/27/2027Opened 9/10/2026

U.S. National Institutes of Health·United States of America

67% match

New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)

Closes 5/7/2027Opened 3/19/2024

U.S. National Institutes of Health·United States of America

67% match

Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)

Closes 11/2/2026Opened 11/6/2023

U.S. National Institutes of Health·United States of America

67% match

Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. National Institutes of Health·United States of America

67% match

Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. National Institutes of Health·United States of America

67% match

Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)

Closes 11/10/2026Opened 8/28/2025

U.S. National Institutes of Health·United States of America

67% match

Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)

Closes 10/28/2027Opened 6/9/2025

U.S. National Institutes of Health·United States of America

67% match

Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

Closes 1/7/2028Opened 11/6/2024